Literature DB >> 2663794

Immunocytochemical localization of the glucose-transport protein in mammalian brain capillaries.

M A Kasanicki1, K R Jessen, S A Baldwin, J M Boyle, A Davies, R M Gardiner.   

Abstract

The endothelial cells of mammalian brain capillaries, which form the anatomical basis of the blood-brain barrier, have been investigated by immunocytochemical methods to determine the distribution of the glucose-transport protein. A monoclonal antibody raised against the intact human erythrocyte glucose-transport protein and polyclonal antibodies raised against a synthetic peptide corresponding to the C-terminal sequence of the human erythrocyte glucose-transport protein were used for immunofluorescent staining of isolated human and bovine cerebral cortex microvessels. The pattern of fluorescence with both antibodies demonstrated the antigen to be distributed throughout the plasma membrane of the capillary endothelial cells. These results provide further evidence for the homology between the human erythrocyte and brain capillary glucose-transport protein, and confirm its abundance in brain capillaries.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663794     DOI: 10.1007/bf01002471

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  14 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Monoclonal antibodies to the glucose transporter from human erythrocytes. Identification of the transporter as a Mr = 55,000 protein.

Authors:  W J Allard; G E Lienhard
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

3.  Peptide-specific antibodies as probes of the orientation of the glucose transporter in the human erythrocyte membrane.

Authors:  A Davies; K Meeran; M T Cairns; S A Baldwin
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

Review 4.  Brain metabolism: a perspective from the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

5.  Proteolytic and chemical dissection of the human erythrocyte glucose transporter.

Authors:  M T Cairns; D A Elliot; P R Scudder; S A Baldwin
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

6.  A D-glucose-sensitive cytochalasin B binding component of cerebral microvessels.

Authors:  S A Baldwin; M T Cairns; R M Gardiner; R Ruggier
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

7.  Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity.

Authors:  A P Dick; S I Harik; A Klip; D M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Distribution of the glucose transporter in the mammalian brain.

Authors:  A P Dick; S I Harik
Journal:  J Neurochem       Date:  1986-05       Impact factor: 5.372

9.  Identification and characterization of the glucose-transport protein of the bovine blood/brain barrier.

Authors:  M A Kasanicki; M T Cairns; A Davies; R M Gardiner; S A Baldwin
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

10.  Characterisation of monoclonal antibodies which specifically recognise the human erythrocyte glucose transport protein.

Authors:  J M Boyle; A D Whetton; T M Dexter; K Meeran; S A Baldwin
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  2 in total

1.  Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature.

Authors:  S R Chipkin; A van Bueren; E Bercel; C R Garrison; A L McCall
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.

Authors:  Florian Stockhammer; Andreas von Deimling; Michael Synowitz; Cristiane Blechschmidt; Frank K H van Landeghem
Journal:  J Mol Histol       Date:  2008-08-26       Impact factor: 2.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.